Vudalimab | PD-1/CTLA-4 bispecific mAb

Chemical Structure : Vudalimab

Vudalimab (XmAb 20717, XmAb 717)

Catalog No.: PC-38873Not For Human Use, Lab Use Only.

Vudalimab (XmAb 20717, XmAb 717) is a bispecific antibody that simultaneously targets immune checkpoint receptors PD-1 and CTLA-4 and is designed to promote tumor-selective T-cell activation.

Packing	Price	Stock	Quantity
1 mg		Get quote
5 mg		Get quote
10 mg		Get quote
25 mg		Get quote
100 mg		Get quote

Get Quotation Now

* Please select Quantity before adding items.

or Bulk Inquiry

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Biological Activity

Vudalimab (XmAb 20717, XmAb 717) is a bispecific antibody that simultaneously targets immune checkpoint receptors PD-1 and CTLA-4 and is designed to promote tumor-selective T-cell activation.
Isotype: Ig half-IG G1-kappa/scFv-h-CH2-CH3.
Anti-[human CTLA4 (cytotoxic T-lymphocyteassociated protein 4, CD152)] and anti-[human PDCD1 (programmed cell death 1, PD-1, PD1, CD279)], monoclonal antibody, bispecific.

Physicochemical Properties

M.Wt
Formula
Appearance	Solid
CAS No.
Storage	Solide Powder -20°C 12 Months; 4°C 6 Months	In Solvent -80°C 6 Months; -20°C 6 Months
Shipping
Solubility	10 mM in DMSO
Chemical Name/SMILES

References

Overnight Delivery
Fast & Safe Delivery Worldwide
Rewards Program

About Us

Our Services

Site Map

Join with Us
Product Use Citations

Pharmacological Glossary Abbreviations

Abbreviations

Quality Manual

Inquiry Form
How to Order

Terms & Conditions

Credit Card Payment

Shipping Rates & Policies

Privacy Policy
sales@probechem.com

Vudalimab (XmAb 20717, XmAb 717)

Biological Activity

Physicochemical Properties

References

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

Get Quote

* Indicates a Required FieldYour information is safe with us.